Berberine Tannate | Interleukin Related interleukin-related.com

Product Name :
Berberine Tannate

Search keywords :
Berberine

drugId :
null

Target Vo:
Unidentified

Target Vo Short Name :
Unidentified

Moa_Name:
Undisclosed

First Approval Country :
Mainland China

First Approval Date Filter:
1985

Origin Company_Name :
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd

Active Company_Name :
The University Of Hong Kong

Active Indication_Name:
Bacterial Infections

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
TRAF2 Rabbit mAb supplier
Hsp70 Rabbit mAb Purity
SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody (YA918): SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody (YA918) is an unconjugated, approximately 46 kDa, mouse-derived, anti-SARS-CoV-2 (2019-nCoV) Nucleocapsid (YA918) monoclonal antibody. SARS-CoV-2 (2019-nCoV) Nucleocapsid Antibody (YA918) can be used for: WB, ELISA expriments in background without labeling.

Author: Interleukin Related

Related Posts